Core Viewpoint - Compliance is essential for the sustainable development of enterprises, and AnTu Bio has integrated compliance into every aspect of its operations, from R&D to financial management [1][2]. Group 1: Compliance Management - AnTu Bio emphasizes compliance training for new employees, incorporating real business scenarios to instill a compliance mindset [2]. - The management team includes compliance decision-making in daily operations, holding monthly simulations to embed compliance responsibilities across all processes [2]. - Supplier compliance management is viewed as a key driver for high-quality development in the industry, with strict standards for supplier qualification and tax credit reviews [2]. Group 2: Tax Policies and R&D Investment - Recent tax reduction policies have provided financial support for enterprises to increase R&D investments, with AnTu Bio investing over 10% of its annual revenue in R&D for the past three years [3]. - AnTu Bio is set to launch 144 new products, including magnetic microparticle chemiluminescence and molecular diagnostics, in 2024 due to its sustained high R&D investment [3]. Group 3: Tax and Compliance Collaboration - The tax authority in Zhengzhou has included AnTu Bio in its "Chief Tax Officer" service list, providing tailored support and monitoring the company's operational status [4]. - A proactive approach to tax management has led to a significant cash flow relief for AnTu Bio, with a recent identification of 2.73 million yuan in incremental tax credits [4]. - AnTu Bio's strong tax credit rating has resulted in a 125.10% increase in bank credit limits since 2020 and a reduction in financing costs by 0.86 percentage points, saving over 8.65 million yuan in financial expenses in 2024 [4].